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Abstract The two branched chain fatty acids pristanic acid 
(2,6,10,14-tetramethylpentadecanoic ac d) and phytanic acid 
(3,7,11,15-tetramethylhexadecanoic acid)were converted to co- 
enzyme A thioesters by rat liver mitochondrial outer membranes. 
However, these branched chain fatty acids could not be converted 
to pristanoyl and phytanoyl carnitines, respectively, by mitochon- 
drial outer membranes. As expected, the unbranched long chain 
fatty acids, stearic acid and palmitic acid, were rapidly converted 
to stearoyl and palmitoyl carnitines, respectively, by mitochon- 
drial outer membranes. These observations indicate that the 
branched chain fatty acids could not be transported into mito- 
chondria. The data presented strongly suggest hat in rat liver, 
c~-oxidation of phytanic acid occurs in organelles other than mito- 
chondria. 
demonstrated that CPTI activity is reversibly inhibited by 
malonyl-CoA. Recently, it has been shown that malonyl-CoA 
inhibits peroxisomal, microsomal and plasma membrane car- 
nitine acyl transferases [8,10,13]. Therefore, in order to under- 
stand the role of CPTI in fatty acid oxidation, CPTI must be 
separated from other carnitine acyl transferases. In view of the 
difficulties in isolating CPTI in the active state, we decided to 
investigate CPTI activity in highly purified mitochondrial outer 
membranes from rat liver. We present evidence that branched 
chain fatty acids with ~- or fl-methyl groups are poor substrates 
for CPTI, suggesting that these branched chain fatty acids 
cannot be transported into mitochondria via the carnitine/ 
acylcarnitine transport system. 
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I. Introduction 
Transport of unesterified long chain fatty acids across mito- 
chondrial membranes i  a complex biochemical process which 
involves the actions of long chain acyl-CoA synthetase, car- 
nitine palmitoyl transferase (CPT) I and II, and possibly car- 
nitine/acyl carnitine translocase. Long chain acyl-CoA synthe- 
tase, which activates fatty acids to fatty acyl-CoA, is located on 
the outer (cytoplasmic) surface of mitochondrial outer mem- 
branes. The catalytic site of CPTI has been shown to be located 
on the inner surface of mitochondrial outer membranes [1,2]. 
Acyl carnitines generated by the action of CPTI are translo- 
cated across the mitochondrial inner membrane by carnitine/ 
acyl carnitine translocase [3]. The catalytic site of CPTII  is on 
the inner (matrix) surface of the mitochondrial inner membrane 
(reviewed by Bieber [4]). 
CPTI has recently been purified from rat liver mitochondria 
and shown to be distinct from CPTII  [5]. Apart from mitochon- 
drial CPTI and II, carnitine acyl transferases have also been 
detected in microsomes, peroxisomes and plasma membranes 
[6-10]. The carnitine acyl transferase or carnitine octanoyl 
transferase (COT) purified from rat, mouse and beef liver is a 
peroxisomal matrix enzyme [6,7,9,11]. Microsomal carnitine 
acyl transferase is not inhibitied by COT or CPTII  antibodies, 
indicating that it is a distinct protein [8]. McGarry et al. [12] first 
*Corresponding author. Fax: (61) (8) 204 7100. 
Abbreviations: CPT, carnitine palmitoyl transferase or carnitine 
acyltransferase; COT, carnitine octanoyl transferase; TLC, thin layer 
chromatography. 
2. Materials and methods 
2.1. Isolation of mitochondria nd mitochondrial outer membranes from 
rat liver 
Liver mitochondria were prepared from adult rats (Porton strain) 
and the purity of the organelles was established [14]. Mitochondrial 
outer membrane fractions were isolated from purified mitochondria 
according to the method of Bhuiyan and Pande [15]. 
2.2. Synthesis of [1-:4C]fatty acids and [1-14C]fatty acyl-CoA 
[1-~4C]Phytanic acid (47 mCi/mmol) was synthesized according to the 
method of Poulos et al. [16]. [1-~4C]Pristanic acid (47 mCi/mmol) was 
synthesized as described previously [17]. The radiolabelled fatty acids 
were purified by thin layer chromatography (TLC) and the structures 
were confirmed by gas chromatography mass spectrometry [18]. The 
radiolabelled purity of fatty acids was > 99%. Radiolabelled fatty acids 
were converted to fatty acyl chloride by reacting with oxalyl chloride, 
and coupled with coenzyme A [19]. The radiolabelled acyl-CoA was 
purified by TLC on silica gel 60 plates using butanol/water/acetic ac d
(60: 20: 7, by volume) as the solvent. Radiolabelled acyl-CoA was visu- 
alised by autoradiography, scraped and eluted from silica gels with 
chloroform/methanol/water (50:50: 10, by volume). Unlabelled phy- 
tanoyl-CoA was synthesized according to the above procedure. Unla- 
belled stearoyl-CoA and palmitoyl-CoA were purchased from Sigma 
Chemical Co., St. Louis, MO, USA. 
2.3. Fatty acyl-CoA synthetase 
Radiolabelled fatty acids were dispersed in ~-cyclodextrin solution 
(20 mM) by sonication [20], and used for acyl-CoA synthetase assay. 
The assay conditions were the same as described for carnitine acyl 
transferase (method 1, see section 2.4.1), except L-carnitine was omitted 
from the incubations. Radiolabelled acyl-CoA produced from 
[1-14C]fatty acid was measured as described previously [21]. 
2.4. Carnitine acyl tran~ferase 
Carnitine acyl transferase activity was assayed by two different pro- 
cedures. 
2.4.1. Method 1. The incubations consisted of 50 mM Tris-HC1 
buffer (pH 8.0), ATP (4 mM), Mg z÷ (4 mM), coenzyme A (0.5 mM), 
dithiothreitol (1 mM) and L-carnitine (2 mM) in a total volume of 
0.2 ml. Radiolabelled fatty acids or fatty acyl-CoA (5-15 ~M) dispersed 
in ~-cyclodextrin (2 mM) were added and incubated at 37°C with 
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indicated amounts of mitochondrial outer membrane proteins. The 
reaction was terminated after 5 min with 4 ml of chloroform/methanol 
(2 : 1, v/v). The solvent was evaporated under a stream of nitrogen and 
the extract was dissolved in methanol/water (80: 20, v/v). In incubations 
where radiolabelled fatty acid was used as a substrate, the unreacted 
substrate was removed by extraction with hexane. Radiolabelled fatty 
acyl-CoA was separated from fatty acyl carnitine by DEAE-Sephacyl 
column (6 x 80 mm) chromatography [22]. Alternatively, after evapora- 
tion of the solvent, the reaction product was chromatographed on TLC 
silica gel 60 plates with butanol/water/acetic acid (60: 20: 7, by volume) 
as the solvent. After chromatography, TLC plates were subjected to 
autoradiography, the acyl carnitine region from silica gel plates was 
scraped, and the radioactivity in acyl carnitine was determined. Negli- 
gible acyl carnitine production was observed when g-carnitine was 
omitted from the incubations. Control experiments without L-carnitine 
were performed with all the substrates investigated. 
2.4.2. Method II. For kinetic experiments, radiolabelled carnitine 
and unlabelled fatty acyl-CoAs were employed. ATP, Mg 2+ and coen- 
zyme A were omitted from the incubations. Fatty acid-free bovine 
serum albumin was included in the incubations to prevent inactivation 
of CPTI due to the detergent effects of fatty acyl-CoAs. The incubations 
consisted of 50 mM sodium phosphate buffer, pH 7.0, dithiothreitol 
(1 mM), e-[methyl-3H]carnitine (40 ¢tCi/,umol, 250/.tM), fatty acid-free 
bovine serum albumin (100/tM) and fatty acyl-CoAs (100 ¢tM) in a 
total volume of 0.1 ml. Incubations were performed at 30°C for 5 rain 
with mitochondrial outer membranes (1-8 pg protein). The reaction 
was terminated with 2 ml of chloroform/methanol (1:1, v/v). Two 
phases were obtained after the addition of 0.5 ml of extraction mixture 
(2 M KC1 containing 0.2 M H3PO4). The upper aqueous phase contain- 
ing radiolabelled carnitine was discarded and the chloroform phase was 
washed once with a 0.5 ml of the extraction mixture (above). Radiola- 
belled product, acyl carnitine, formed during the incubations was ex- 
tracted into the chloroform phase and was quantified. We find that acyl 
carnitines with acyl moieties > 10 carbons in length were quantitatively 
extracted in the chloroform phase. Control experiments without mito- 
ehondrial outer membranes were performed with each set of assays. 
Control experiments indicated that <0.1% of radiolabelled substrate 
(carnitine) was extracted into the chloroform phase under the above 
extraction conditions. 
2.5. Monoamine oxidase 
Tyramine was employed as the substrate for monoanaine oxidase, 
and substrate-dependent H202 production was measured fluorometri- 
cally. The detection method was based upon the conversion of non- 
fluoroscent homovanillic acid to a highly fluorescent dimer in the pres- 
ence of free radicals [23]. The incubations consisted of 50 mM Tris-HC1 
buffer, pH 8.0, tyramine (1 mM), Triton X-100 (0.1%), horseradish 
peroxidase (40/lg/incubation) and homovanillic acid (80 pg/incubation) 
in a total volume of 0.2 ml. Incubations were performed with rat liver 
factions (3 30 ¢tg protein) at 37°C for 30 min. The reaction was termi- 
nated with 1 ml of 50 mM KOH, and the fluorescent product formed 
during the incubations was quantified fluorometrically (excitation 310 
rim, emission 420 nm). Control incubations without the enzyme and 
also without substrate were included with each liver fraction. 
2.6. Other marker enzymes 
The assay conditions for uric acid oxidase were similar to those 
described above for monoamine oxidase. Uric acid oxidase activity was 
determined using 50 mM sodium phosphate buffer, pH 8.0, and 1 mM 
uric acid as a substrate. Incubations were performed at 37°C for 15 min 
using 25-100 ¢tg of liver fractions as an enzyme source. Acyl-CoA 
oxidase assays were performed at 37°C for 10 rain using palmitoyl-CoA 
(0.25 mM) as a substrate [24]. The assay conditions for dihydroxyace- 
tone phosphate acyltransferase and ~-ketoglutarate d hydrogenase 
were essentially the same as described previously [14,24]. Protein con- 
tent in liver fractions was determined fluorometrically [25] using human 
serum albumin as a standard. 
3. Results 
It is evident from Table 1 that purified mitochondr ia  was 
enriched in monoamine oxidase (mitochondrial  outer mem- 
brane enzyme) and ~-ketoglutarate d hydrogenase (mitochon- 
drial matrix enzyme) activities. There was at least 15-fold en- 
r ichment o fmonoamine  oxidase activity in mitochondrial  outer 
membranes compared to purified mitochondr ia (Table 1). Only 
small amounts of ~-ketoglutarate d hydrogenase activity was 
detected in purified mitochondrial  outer membranes. Succinate 
dehydrogenase (a mitochondrial  inner membrane nzyme) ac- 
tivity could not be detected in purified outer membrane prepa- 
rations (data not given), suggesting further that mitochondrial  
outer membrane preparations contain negligible (< 3%) mito- 
chondrial contamination. Plasma membrane nzyme (5'-nucle- 
otidase) activity could not be detected either in purified mito- 
chondria or mitochondrial  outer membranes, indicating that 
these preparations were free of plasma membranes.  Negligible 
activity of dihydroxyacetone phosphate acyltransferase (a per- 
oxisomal membrane nzyme) was detected in purified mito- 
chondria and mitochondrial  outer membranes compared to 
purified peroxisomes (Table 1). Also, acyl-CoA oxidase (a per- 
oxismal matrix enzyme) and uric acid oxidase (a peroxisomal 
core enzyme) activities were negligible in purified mitochon- 
dria, and these enzyme activities could not be detected in puri- 
fied mitochondrial  outer membrane preparations (Table 1). 
Thus, it is evident hat highly purified mitochondr ia nd mito- 
chondrial outer membrane preparations were employed for 
investigations of acyl-CoA synthetase and carnit ine acyltrans- 
ferase activities. 
Acyl-CoA synthetase activity in purified mitochondr ia was 
linear with protein up to 2¢tg and incubation period up to 5 min 
using stearic acid as a substrate. Comparable activities of acyl- 
CoA synthetase were detected in purified mitochondr ia using 
palmitic and stearic acids as substrates. The branched chain 
fatty acids, namely pristanic and phytanic acids, were also rap- 
idly converted to coenzyme A thioesters by purified mitochon- 
dria. Acyl-CoA synthetase activities towards stearic, pristanic 
and phytanic acids using purified mitochondr ia were, respec- 
tively, 87, 65 and 47 nmol/min per mg protein. Purified mito- 
chondrial outer membranes effectively converted fatty acids to 
coenzyme A thioesters. Mitochondria l  outer membrane acyl- 
CoA synthetase activities towards stearic, pristanic and 
phytanic acids were, respectively, 164, 172 and 80 nmol/min per 
mg protein. There was a twofold enrichment of acyl-CoA syn- 
Table 1 
Marker enzyme activities (nmol/min/mg protein) in liver homogenate, 
purified mitochondria and mitochondrial outer membranes 
Marker enzyme Liver Purified Mito- 
homogenate mito- chondrial 
chondria outer 
membranes 
Monoamine oxidase 4.5 13.6 212.6 
ct-Ketoglutarate 
dehydrogenase 3.4 9.0 0.3 
Dihydroxyacetone 
phosphate acyl 
transferase 2.5 0.7 0.6 
Acyl-CoA oxidase 3.8 0.7 0 
Uric acid oxidase 4.0 1.7 0 
Marker enzyme activities were assayed as described in section 2, and 
the data in nmol/min/mg protein are presented as an average of two 
observations. Acyl-CoA oxidase activity was determined using palmi- 
toyl-CoA as a substrate. Dihydroxyacetone phosphate acyltransferase, 
acyl-CoA oxidase and uric acid oxidase activities were at least fiftyfold 
higher in purified peroxisomes compared to liver homogenate. The data 
are representative of three experiments. 
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Fig. 1. Autoradiographs of the reaction products formed from free fatty 
acids and fatty acyl-CoAs by incubations with mitochondrial outer 
membranes. [l-J4C]Fatty acids (A) or [1-14C]fatty acyl-CoAs (B) were 
incubated (see section 2.4.1) with rat liver mitochondrial outer mem- 
branes (4.8 j.tg protein). The reaction product was chromatographed on 
TLC silica gel 60 plates and the plates were subjected toautoradiogra- 
phy for 12 days. Fatty acid substrates employed were: C18:0 acid, 
stearic acid; C19:0 (br) acid, pristanic acid; C20:0 (br) acid, phytanic 
acid. Lanes with - represent incubations performed without L-carnitine 
and + represent the incubations in the presence of 2 mM c-carnitine. 
FA, fatty acid; ACarn, acyl carnitine; ACoA, acyl-CoA; O, origin of 
applications of reaction products on TLC plates. 
thetase activity in mitochondrial outer membranes compared 
to purified mitochondria, suggesting that the enzyme was par- 
tially inactivated uring preparation and purification of mi- 
tochondrial outer membranes. 
Mitochondria contain both CPTI and CPTII, whereas mito- 
chondrial outer membranes contain only CPTI. Therefore, mi- 
tochondrial outer membranes were employed for investigations 
into CPTI activity. Stearic acid, as well as stearoyl-CoA, were 
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Table 2 
Carnitine acyl transferase activity (nmol/min/mg protein) in rat liver 
mitochondrial outer membranes 
Substrate Acyl carnitine formed from radiolabelled 
fatty acids or fatty acyl-CoAs 
Stearate Pristanate Phytanate 
Free fatty acid 5.3 0 0.2 
Fatty acyl-CoA 6.9 0.1 0.2 
[1-14C]Fatty acids (5 15 pM) or [1-~4C]fatty acyl-CoAs (1(~12 pM) 
were incubated with mitochondrial outer membranes (4.8 ,ug protein) 
as described (see section 2.4.1.). Acyl carnitine was separated from 
acyl-CoA by DEAE-Sephacyl column chromatography [22], and radio- 
labelled acyl carnitine produced from radiolabelled fatty acid or fatty 
acyl-CoA was determined. The values, in nmol/min/mg protein, repre- 
sent an average of two determinations. The experiments were repeated 
and similar esults were obtained. 
effectively converted to stearoyl carnitine by mitochondrial 
outer membranes (Table 2, Fig. 1). Similar results were ob- 
tained using palmitic acid and palmitoyl-CoA as substrates 
(data not given). Pristanic and phytanic acids and their coen- 
zyme A thioesters were poor substrates for the mitochondrial 
outer membrane enzyme (Table 2, Fig. 1). It is evident hat 
higher enzyme activities were observed with phytanic acid or 
phytanoyl-CoA as a substrate compared to pristanic acid or 
pristanoyl-CoA (Table 2, Fig. 1). Quantification of radiola- 
belled acyl carnitine production from radiolabelled fatty acids 
or fatty acyl-CoAs was carried out by two different procedures, 
namely thin layer chromatography (Fig. 1) and DEAE-Se- 
phacyl column chromatography (see section 2, Table 2). The 
acyl carnitine region from thin layer plates was also scraped and 
radioactivity was quantified. Quantification f the radioactivity 
in the acyl carnitine region of the chromatographic plates gave 
identical results, as described in Table 2 (determined by DEAE- 
Sephacyl column chromatography). 
In order to establish whether phytanic acid can or can not 
be transported into mitochondria via the carnitine/acyl car- 
nitine transport system, we performed etailed kinetic experi- 
ments using unlabelled phytanoyl-CoA and radiolabelled car- 
nitine as substrates, and mitochondrial outer membranes a an 
enzyme source. For comparison, unlabelled palmitoyl-CoA 
was employed as a substrate. Palmitoyl carnitine production 
from palmitoyl-CoA was inhibited by malonyl-CoA (>50% 
inhibition with 2 pM malonyl-CoA). Significantly ower inhibi- 
tion by malonyl-CoA was observed when the enzyme assays 
were performed at 37°C compared to 30°C and at pH 8.0 
compared to pH 7.0 (data not given). Significantly lower ma- 
lonyl-CoA inhibition was observed when fatty acid-free bovine 
serum albumin was omitted from the incubations. These obser- 
vations uggest that malonyl-CoA dissociates from CPTI rap- 
idly at higher pH and higher temperature, and the free concen- 
tration of palmitoyl-CoA (substrate) in the incubations deter- 
mine the rate and extent of inhibition by malonyl-CoA. 
Under optimal assay conditions and using palmitoyl-CoA as 
substrate, palmitoyl carnitine production increased with time 
and the enzyme activity was linear at least up to 10 min. How- 
ever, under the same conditions with phytanoyl-CoA as a sub- 
strate, the enzyme activity was negligible and the activity did 
not increase with time (Fig. 2A). Palmitoyl carnitine production 
increased with increasing concentrations of protein, and the 
reaction was linear, at least up to 7.5 pg protein/assay. Under 
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Fig. 2. Time~zourse and protein curve with palmitoyl-CoA or phytanoyl-CoA as a substrate for carnitine palmitoyltransferase I. Carnitine 
acyltransferase assays were performed for indicated periods (A) with 5.7/.tg of mitochondrial outer membranes or with indicated amounts of 
mitochondrial outer membranes (B) for 5 min at 30°C (see section 2.4.2). Each point on the graph represents an average of two observations. 
the same conditions, phytanoyl carnitine production from phy- 
tanoyl-CoA was negligible, and the enzyme reaction did not 
increase with increased amounts of enzyme protein in the incu- 
bations (Fig. 2B). 
In order to eliminate the possibility that higher concentra- 
tions (100 J2M) of phytanoyl-CoA employed might inhibit 
CPTI, we carried out substrate saturation kinetics with phy- 
tanoyl-CoA, as well as palmitoyl-CoA and L-carnitine (Fig. 
3A,B). Palmitoyl carnitine production increased with increas- 
ing concentrations of L-carnitine or palmitoyl-CoA in the incu- 
bations. Typical hyperbolic substrate saturation curves were 
observed with both L-carnitine and palmitoyl-CoA. However, 
phytanoyl carnitine production was negligible under these con- 
ditions, and the rate of  reaction did not change with the increas- 
ing concentrations of phytanoyl-CoA in the incubations. Ap- 
parent Km and Vma x with palmitoyl-CoA and L-carnitine were 
E 
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55 and 42 pM, and 26 and 21 nmol/min per mg protein, respec- 
tively. 
It is known that bovine serum albumin binds fatty acids and 
fatty acyl-CoAs. It is possible that bovine serum albumin added 
to incubations may tightly bind phytanoyl-CoA, and that albu- 
min-bound phytanoyl-CoA may not be available to the enzyme. 
To address this question, we excluded bovine serum albumin 
from the incubations and repeated the substrate saturation 
kinetic experiments. Again, a hyperbolic palmitoyl-CoA satu- 
ration curve was observed at the lower concentrations of the 
substrate, and higher concentrations of the substrate were in- 
hibitory (Fig. 3C), possibly due to detergent action. Apparent 
K m and Vma x with palmitoyl-CoA were 18 pM and 77 nmol/min/ 
mg protein, respectively. CPTI activity with phytanoyl-CoA 
was negligible at all the substrate concentrations examined 
(Fig. 3C). 
I ° Palmitoyl CoA ~" ~ Phytanoyl CoA "~ 60 
Q. 
50 - 
E ~ 40 - 
~ 30 - 
E 
21o-  
0-  
0 5; 1()0 1;0 2;0 
Acyl CoA concentration (pM) 
Fig. 3. Substrate saturation kinetic studies with carnitine palmitoyl transferase I. Mitochondrial outer membranes (7.6 #g protein) were incubated 
at 30°C for 5 min. with 100/zM palmitoyI-CoA and indicated concentrations of L-carnitine (A), 250/IM L-carnitine and indicated concentrations 
of palmitoyl-CoA or phytanoyl-CoA (B,C). Equimolar concentrations of acyl-CoA and fatty acid free bovine serum albumin were maintained in 
the incubations (A,B) or fatty acid free bovine serum albumin was omitted from the incubations (C) and acyl carnitine production was measured 
(see Method II of carnitine acyltransferase assay). Each point on the graph represents an average of two observations. 
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4. Discussion 
The data presented clearly indicate that both the unbranched 
and branched long chain fatty acids are activated to acyl-CoAs 
by the mitochondrial outer membrane acyl-CoA synthetase. It 
is not clear at present whether the branched chain fatty acids 
are activated by a distinct branched chain acyl-CoA synthetase 
or by a non-specific long chain acyl-CoA synthetase located in 
the mitochondrial outer membranes. Pristanic acid with an 
a-methyl group can be degraded by fl-oxidation, whereas 
phytanic acid with a fl-methyl group can only be degraded by 
a-oxidation. The naturally occurring branched chain fatty acids 
containing either an a-methyl or a fl-methyl group can be effec- 
tively activated to acyl-CoA by mitochondrial outer membrane 
acyl-CoA synthetase. However, both these fatty acids are poor 
substrates for CPTI (Table 2, Figs. 1-3). It is well accepted that 
long chain fatty acids are transported across the mitochondrial 
membranes via a carnitine/acyl carnitine transport system (see 
section 1). Our data clearly demonstrate hat CPTI is highly 
specific for unbranched chain fatty acids. The fact that both the 
branched chain fatty acids, namely pristanic and phytanic 
acids, can not be converted to acyl carnitine by CPTI clearly 
indicates that pristanic and phytanic acids cannot be trans- 
ported into mitochondria via the carnitine/acyl carnitine trans- 
port system. Thus it is unlikely that pristanic and phytanic 
acids, the two branched chain fatty acids, are oxidized in rat 
liver mitochondria. Recent studies from our laboratory [17,26] 
provide evidence that in human skin fibroblasts, pristanic acid 
oxidation occurs mainly in peroxisomes. 
In contrast to fl-oxidation, the exact intracellular localisation 
of c~-oxidation is poorly understood. Recent studies in human 
liver and skin fibroblasts [27-29] suggest hat a-oxidation of 
phytanic acid is peroxisomal, whereas in rat liver the oxidation 
is mitochondrial [28]. However, previous tudies in rat, human 
and monkey liver suggested that a-oxidation occurs in mito- 
chondria [30-33]. Also, the report hat phytanic acid oxidation 
is defective in patients with cytochrome c oxidase deficiency [34] 
indicates that mitochondria are involved in the production of 
radiolabelled CO 2 from [1-~4C]phytanic a id. A report that a- 
oxidation of phytanic acid is mainly microsomal in rat liver [35] 
further adds to the confusion. In all of these studies, radiola- 
belled CO2 production from [1-~4C]phytanic a id was taken as 
evidence of c~-oxidation. Furthermore, a-oxidation activities 
measured were very low [27-35]. Recent studies from our labo- 
ratory [36] provide evidence that formic acid is the major ~- 
oxidation product in human skin fibroblasts. Formic acid pro- 
duction is deficient in Zellweger syndrome fibroblasts, indicat- 
ing that formic acid production from phytanic acid is per- 
oxisomal, although the exact mechanism of a-oxidation of 
phytanic acid is poorly understood at present. The evidence 
presented herein clearly indicate that phytanic acid a-oxidation 
in rat liver is unlikely to be mitochondrial. Further studies are 
required to understand the exact mechanism(s) of phytanic acid 
oxidation and to clarify the intracellular site of a-oxidation. 
Acknowledgements: The authors are thankful to Dr. David Johnson for 
the synthesis ofradiolabelled pristanic and phytanic acids, and Ms. Peta 
Knapman for typing the manuscript. The work was supported by 
the grants from the Women's and Children's Hospital Research Foun- 
dation and the National Health and Medical Research Council of 
Australia. 
References 
[1] Murthy, M.S.R. and Pande, S.V. (1987) Proc. Natl. Acad. Sci. 
USA 84, 378 382. 
[2] Kashfi, K. and Cook, G.A. (1992) Biochem. J 282, 909-914. 
[3] Bremer, J. (1983) Physiol. Rev. 63, 1420 1480. 
[4] Bieber, L.L. (1988) Annu. Rev. Biochem. 57, 261-283. 
[5] Kolodziej, M.P., Crilly, P.J. Corstorphine, G.C. and Zammit, 
V.A. (1992) Biochem. J 282, 415-421. 
[6] Miyazawa, S., Ozasa, H., Osumi, T. and Hashimoto, T. (1983) 
J. Biochem. (Tokyo) 94, 529-542. 
[7] Farrell, S.O. and Bieber, L.L. (1983) Arch. Biochem. Biophys. 222, 
123-132. 
[8] Lilly, K., Bugaisky, G.E., Umeda, P.K. and Bieber, L.L. (1990) 
Arch. Biochem. Biophys. 280, 167-174. 
[9] Ramsay, R.R., Derrick, J.E, Friend, A.S. and Tubbs, P.K. (1987) 
Biochem. J 244, 271-278. 
[10] Ramsay, R.R., Mancinelli, G. and Arduini, A. (1991) Biochem. J. 
275, 685-688. 
[11] Ramsay, R.R. (1988) Biochem. J 249, 239~45. 
[12] McGarry, J.D., Leatherman, G.F. and Foster, D.W. (1978) 
J. Biol. Chem. 253, 4128-4136. 
[13] Derrick, J.P. and Ramsay, R.R. (1989) Biochem. J 262, 801- 
806. 
[14] Singh, H., Beckman, K. and Poulos, A. (1993) J. Lipid Res. 34, 
467-477. 
[15] Bhuiyan, A.K.J.M. and Pande, S.V. (1992) Lipids 27, 392-395. 
[16] Poulos, A., Barone, E. and Johnson, D. (1980) Lipids 15, 19 21. 
[17] Singh, H., Usher, S., Johnson, D. and Poulos, A. (1990) J. Lipid 
Res. 31,217 225. 
[18] Poulos, A., Sharp, R, Fellenberg, A.J. and Johnson, D.W. (1988) 
Eur. J. Pediatr. 147, 143-147. 
[19] Singh, H., Derwas, N. and Poulos, A. (1987) Arch. Biochem. 
Biophys. 254, 52(~533. 
[20] Singh, H. and Poulos, A. (1986) Arch. Biochem. Biophys. 250, 
171-179. 
[21] Singh, H. and Poulos, A. (1988) Arch. Biochem. Biophys. 266, 
486495. 
[22] Watmough, N.J., Turnbull, D.M., Sherratt, H.S.A. and Bartlett, 
K. (1989) Biochem. J 262, 261-269. 
[23] Guilbault, G.G., Brigmac Jr., P. and Zimmer, M. (1968) Anal. 
Chem. 40. 19~196. 
[24] Singh, H., Derwas, N. and Poulos, A. (1987) Arch. Biochem. 
Biophys. 259, 382-390 
[25] Udenfriend, S., Stein, S., Bohlen, E, Dairman, W., Leimgruber, 
W. and Weigele, M. (1972) Science 178, 871-872. 
[26] Singh, H., Brogan, M., Johnson, D. and Poulos, A. (1992) J. Lipid 
Res. 33, 1597-1605. 
[27] Singh, I., Lazo, O., Kgiipada, P. and Singh, A.K. (1992) Biochim. 
Biophys. Acta. 1180, 221-224. 
[28] Singh, I., Pahan, K., Lazo, O., Dhaunsi, G.S. and Ozand, P. (1993) 
J. Biol. Chem. 268, 9972-9979. 
[29] Singh, I., Pahan, K., Singh, A.K. and Barbosa, E. (1993) J. Lipid 
Res. 34, 1755 1764. 
[30] Muralidharan, V.B. and Kishimoto, Y. (1984) J. Biol. Chem. 259, 
13021 13026. 
[31] Skjeldal, O.H. and Stokke, O. (1987) Biochim. Biophys. Acta 921, 
38-42. 
[32] Watkins, RA., Mihalik, S.J. and Skjeldal, O.H. (1990) Biochem. 
Biophys. Res. Commun. 167, 5813~586. 
[33] Wanders, R.J.A., Van Roermund, C.W.T., Jakobs, C. and Ten- 
Brink, H.J. (1991) J. Inher. Metab. Dis. 14, 349 352. 
[34] Wanders, R.J.A. and Van Roermund, C.W.T. (1993) Biochim. 
Biophys. Acta 1167, 345-350. 
[35] Huang, S., Van Veldhoven, P.R, Vanhoutte, F., Parmentier, G., 
Eyssen, H.J. and Mannaerts, G.E (1992) Arch. Biochem. Biophys. 
296, 214-223. 
[36] Poulos, A., Sharp, P., Singh, H., Johnson, D., Carey, W.F. and 
Easton, C. (1993) Biochem. J 292, 457-461. 
